Scaling up Genomics
Clinical Journal of the American Society of Nephrology · 2026-11 · 21 (11) · 1968-1980
DOI: 10.2215/cjn.0000001184 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 17.08.2026. Verfasst von Kushani Jayasinghe und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Medical Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Nephrology, Genomics, Genetic Testing, Kidney Diseases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Melbourne Genomics, State Government of Victoria, Royal Australian College of Physicians, Melbourne Genomics, State Government of Victoria.
Abstract (Originalsprache)
Key Points We evaluated a hub and spoke mainstreaming model to enable nephrologists to order genomic tests independently in their clinic across the state of Victoria. Over 1000 tests were ordered, with the diagnostic yield remaining similar regardless of ordered by local nephrologists or tertiary genomics services. A mainstreaming model proved feasible, scalable, and clinically effective, offering a practical framework for integrating genomics to routine kidney care.
Background
Genomic testing has substantial diagnostic and clinical value in nephrology, yet integrating testing into routine care requires service-level changes to ensure timely and equitable access.
Methods
We conducted an observational cohort study at four tertiary centers, with a pragmatic, quasi-experimental design to evaluate evidence-informed, service-level interventions to make genomic testing more accessible and routinely embedded within nephrology practice. We implemented a hub and spoke model which provided nephrologists with training, practical resources, and regular case-based discussions, to support test ordering and interpretation within their own clinics. Laboratory audits (June 2021–July 2024) evaluated how public reimbursement and implementation interventions influenced testing patterns. Three periods were compared: prefunding, postfunding, and postintervention.
Results
Across the study period, 1028 genomic tests were ordered (63% adults, 37% children; median age 32 years). Results were available for 1014 tests, with an overall diagnostic yield of 34%, which remained stable across all time points. The diagnostic yield was similar regardless of whether testing occurred at tertiary genomics services (249 of 772, 32%) or via local nephrologists (92 of 242, 38%). The number of unique providers ordering tests was higher (T1: 37, T2: 69, T3: 87). The proportion of testing in mainstream nephrology settings rose from 23% to 74%, while absolute testing numbers in multidisciplinary clinics remained consistent over the study period.
Conclusion
Mainstreaming genomic testing in nephrology was feasible, scalable, and clinically effective. This model was associated with better access without compromising diagnostic yield and provides a practical framework for integrating genomic medicine into routine kidney care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Medical Centre, Melbourne, Victoria, Australia.
- School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
- Department of Genomic Medicine, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
- Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
ORCID-Profile: Kushani Jayasinghe, Rigan Tytherleigh, Stephanie Best, Simon Bodek, Grainne Butler, Ainsley Campbell, Amy Clarke, Brendan Cusack, Elizabeth Donaldson, Clara Gaff, Asheeta Gupta, Paul James, Emma Krzesinski, Anna Leaver, Mandy Law, Po Yee Mia Leung, Sebastian Lunke, Melissa Martyn, Briannah Miles, Kathleen Nicholls, Jessica Ryan, Judy Savige, Bryony Thompson, Alison Trainer, Giulia Valente, Kathryn Visser, Andrea Ward, Jack Wheeler, John Whitlam, Ella J Wilkins, Zornitza Stark, Catherine Quinlan
Förderung
- Melbourne Genomics, State Government of Victoria, Royal Australian College of Physicians
- Melbourne Genomics
- State Government of Victoria
- Royal Australian College of Physicians
Zitieren
APA
Jayasinghe, K., Tytherleigh, R., Best, S., Bodek, S., Bussa, P., Butler, G., Campbell, A., Clarke, A., Cusack, B., Donaldson, E., Elbaum, Y., Gaff, C., Gear, R., Gupta, A., James, P., Johnstone, L., Kerr, P. G., Krzesinski, E., Leaver, A., …, & Quinlan, C. (2026). Scaling up Genomics. Clinical Journal of the American Society of Nephrology, 21(11), 1968-1980. https://doi.org/10.2215/cjn.0000001184
Vancouver
Jayasinghe K, Tytherleigh R, Best S, Bodek S, Bussa P, Butler G, et al. Scaling up Genomics. Clinical Journal of the American Society of Nephrology. 2026;21(11):1968-1980. doi:10.2215/cjn.0000001184
BibTeX
@article{Jayasinghe2026,
author = {Jayasinghe, Kushani and Tytherleigh, Rigan and Best, Stephanie and Bodek, Simon and Bussa, Paula and Butler, Grainne and Campbell, Ainsley and Clarke, Amy and Cusack, Brendan and Donaldson, Elizabeth and Elbaum, Yoni and Gaff, Clara and Gear, Russell and Gupta, Asheeta and James, Paul and Johnstone, Lilian and Kerr, Peter G and Krzesinski, Emma and Leaver, Anna and Lazarus, Benjamin and Law, Mandy and Leung, Po Yee Mia and Lunke, Sebastian and Martyn, Melissa and Miles, Briannah and Nicholls, Kathleen and Pang, Lokman and Regan, Matthew and Ryan, Jessica and Savige, Judy and Thompson, Bryony and Trainer, Alison and Valente, Giulia and Visser, Kathryn and Ward, Andrea and Wheeler, Jack and Whitlam, John and Wilkins, Ella J and Winship, Ingrid and Xie, Kenneth and Stark, Zornitza and Quinlan, Catherine},
title = {Scaling up Genomics},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {11},
pages = {1968--1980},
doi = {10.2215/cjn.0000001184}
}
EUVIMED